Drug Trial Radar · NCT05065983
A Study to Assess the Safety and Immunogenicity of PXVX0317 Chikungunya Virus Virus-Like Particle Vaccine
Last checked: Nov 20, 2026Latest source record: Jul 3, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
25
Actual
Start
Oct 11, 2021
Primary completion
May 5, 2022
Study completion May 5, 2022
Sponsor
- Lead sponsor
- Bavarian NordicIndustry
- Sponsor type
- Industry
- Collaborators
- Emergent BioSolutions
- First posted
- Oct 4, 2021
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 45 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The objective of this study is to assess the safety and immunogenicity of PXVX0317 (Chikungunya Virus Virus-Like Particle Vaccine \[CHIKV VLP\], aluminum hydroxide adjuvanted).
Conditions
- Chikungunya Virus
Interventions
CHIKV VLP, adjuvantedBiological
Adjuvanted formulation includes aluminum hydroxide
Primary outcomes
What the sponsor says the trial is designed to measure.
- CHIKV SNA (Serum Neutralizing Antibody) Seroresponse Rate at Day 22Time frame: 21 days post vaccination
- CHIKV SNA GMT (Geometric Mean Titer) at Day 22Time frame: 21 days post vaccination
- CHIKV SNA Seroresponse Rates at Days 8, 15, and 57Time frame: 56 days post vaccination
- CHIKV SNA GMTs at Days 8, 15, and 57Time frame: 56 days post vaccination
- CHIKV ELISA (Enzyme-Linked Immunosorbent Assay) IgG GMTs at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
- CHIKV ELISA IgM GMTs at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
- Geometric Mean Fold Increase (GMFI) in CHIK SNA Titers at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
- GMFI in CHIK ELISA IgG at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
- GMFI in CHIK ELISA IgM at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
- Number and Percentage of Participants With a CHIKV SNA Titer at or Above Threshold Values at Days 8, 15, 22, and 57Time frame: 56 days post vaccination
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Johnson County ClinTrials
Lenexa, Kansas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.